Recombinant Human FGFR1 beta (IIIc) Protein, Active
Beta LifeScience
SKU/CAT #: BLK-02169P-100UG
Human FGFR1 beta (IIIc) on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human FGFR1 beta (IIIc) Protein, Active
Beta LifeScience
SKU/CAT #: BLK-02169P-100UG
Collections: Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human FGFR1 beta (IIIc) Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Lys158-Thr355. |
Purity | > 95% as determined by Tris-Bis PAGE |
Accession | P11362 |
Target Symbol | FGFR1 beta (IIIc) |
Synonyms | Fibroblast growth factor receptor 1;FGFR-1;Basic fibroblast growth factor receptor 1;BFGFR;bFGF-R-1;Fms-like tyrosine kinase 2;FLT-2;N-sam;Proto-oncogene c-Fgr;CD_antigen: CD331; |
Species | Human |
Expression System | HEK293 |
Tag | C-His-Avi |
Expression Range | Lys158-Thr355 |
Mol. Weight | The protein has a predicted MW of 25.23 kDa. Due to glycosylation, the protein migrates to 45-55 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized Anti-FGFR1 Anitibody, hFc Tag at 2ug/ml (100ul/Well) on the plate. Dose response curve for Human FGFR1 beta (IIIc) , His Tag with the EC50 of 0.62ug/ml determined by ELISA. Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | Fibroblast growth factor receptor 1 (FGFR1) transmits signals through the plasma membrane regulating essential cellular processes like division, motility, metabolism, and death. Overexpression of FGFR1 is observed in numerous tumors and thus constitutes an attractive molecular target for selective cancer treatment. |